Igor Gonikhin

Mizuho Securities USA LLC is the US-based securities broker/dealer and futures commission merchant arm of Mizuho Americas LLC, ultimately held by Mizuho Financial Group, Inc. (TYO: 8411, NYSE: MFG) in Japan. Headquartered in New York City, the firm was founded in 1994 and provides institutional and corporate clients access to commodity and financial markets around the world. Mizuho Securities USA covers the following industries: Consumer, Energy, Financial Institutions, Financial Sponsors, Healthcare, Industrial & Diversified Industries, Power, Utilities & Infrastructure, Real Estate, and Technology, Media & Telecom (TMT). The firm and their affiliates hold memberships on all major futures and options exchanges worldwide.

RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Dharmacon, Inc. engages in the research and development for ribonucleic acid synthesis. Its products are gene editing, RNA interference, cDNAs and ORFs, transfection, and viral packaging. The company was founded by Stephen Scaringe in 1995 and is headquartered in Lafayette, CO.

Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD.

Otsuka Pharmaceutical Europe Ltd. markets drugs, nutraceuticals and other health care products manufactured by its Japan-based parent, Otsuka Pharmaceutical. Some of the company's nutraceutical products include Pocari Sweat-electrolyte replacement beverages, Calorie Mate-energy beverages and the Calcium. Otsuka also makes products for infants under the Bean Stalk name. Additionally, the company conducts pharmaceutical research focusing on gastroenterology, oncology, dermatology, ophthalmology and the cardiovascular system. The company was founded in 1998 and is headquartered in Uxbridge, UK

Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom.

Bioprocess Capital Partners Ltd (BCP) is a venture capital firm founded in 2006. The firm is headquartered in Moscow, Russia.

R-Pharm JSC engages in the research, development, and manufacture of medicines. It also distributes laboratory supplies and medical equipment. The company was founded by Alexey Yevgenyevich Repik on August 17, 2001 and is headquartered in Moscow, Russia.

R-Pharm CJSC engages in the manufacture and distribution of pharmaceuticals and drugs. Its activities include research and development, manufacturing, marketing, sales and distribution of pharmaceuticals used in hospital and specialty care. The company was founded by Alexey Evgenyevich Repik in 2001 and is headquartered in Moscow, Russia.

Part of The McClay Foundation, Almac Diagnostics 2004 Ltd. is a British dormant company. The company is based in Craigavon, UK. Almac Diagnostics 2004 was founded in 2004.

Part of Karl und Anna Buck Stiftung, Buck-Chemie GmbH is a company headquartered in Herrenberg, Germany. The firm manufactures cleaning products. It was founded in 1966 by Karl Buck and Ann Buck. Werner Müller is currently the CEO of the company. The company says this about itself: A typical medium-sized company from Swabia? With its roots in the regional capital, Stuttgart, Precisely. Since 1966, we have been developing, producing and constantly improving consumer products for cleaning, fragrance and care, with a focus on WC-cleaning, from our headquarters in Herrenberg - for customers across the globe! Buck Chemie handles the entire process chain, from A to Z. We are known for our flexible approach to development, for our established know-how and for our focus on customer needs. We provide comprehensive support, all the way through from the original idea to successful launch.

Guggenheim Securities LLC (Research) (Guggenheim Securities-RE) is the investment research division of Guggenheim Securities LLC, a financial services firm headquartered in New York City. The firm is a subsidiary of Links Holdings LLC, which is owned by Guggenheim Partners LLC. Guggenheim Securities-RE offers equity research for institutional investors in their research focus sectors: Consumer, Energy & Power, Healthcare, and Technology & Media.

Bonti, Inc. develops novel treatments. It specializes in both aesthetic and therapeutic indications. The company was founded by Fauad Hasan, Mike Jarpe, Wajdie Ahmad, Jonathan Lim, David Ramsay and Susan Abushakra in 2015 and is headquartered in Newport Beach, CA.

Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Staines Upon Thames, UK and was founded in 2015.

Dragonfly Therapeutics, Inc. develops therapy to stimulate immune responses against cancer. The company was founded by Tyler Jacks, Bill Haney and David Raulet in 2015 and is headquartered in Waltham, MA.

National Bioservice LLC engages in conducting biotechnology research. Its services include biobanking, fixation and storage of bio specimens, DNA/RNA technologies & bioinformatics and counselling. The company was founded in March 2014 and is headquartered in St. Petersburg, Russian Federation.

Part of Silence Therapeutics Plc, Silence Therapeutics GmbH is a German biotechnology company that develops RNAi-based drugs. The company is based in Berlin, Germany and was founded in 2014.

Diagonal Therapeutics, Inc. is a biotechnology company located in the US that develops drugs for oncology, immunology, and rare diseases.